Advanced Diagnostic Yields
Vinsi AI's Ion integrated with mobile cone-beam CT offers a groundbreaking 90% approximate diagnostic yield, as defined by ATS/ACCP, ensuring accurate results for pulmonary care teams.
Minimal Complication Rates
With an impressive 0% incidence of any pneumothorax, Ion's innovative approach to robotic bronchoscopy showcases a commitment to patient safety and overall procedural success.
Enhanced Nodule Evaluation
The median nodule diameter of 14mm and the presence of the bronchus sign in 26.5% of nodules emphasize Ion's ability to accurately assess and target lung nodules, crucial for effective biopsy procedures.
Evidence-backed Outcomes
Extensive research supports the exceptional outcomes of Ion in lung nodule management, with data from high-quality studies consistently demonstrating the system's efficacy and reliability in clinical settings.
Research Grants and Support
The Intuitive Foundation actively offers research grants to foster advancements in robotic and pulmonary nodule management, providing critical financial support for innovative research initiatives in the field.
Health Economics Outcomes Research
Intuitive's dedication to Health Economics Outcomes Research (HEOR) ensures a comprehensive understanding of Ion's impact on the patient journey, shedding light on the system's potential value in lung nodule biopsy.
Clinical Evidence and Validation
Recent clinical studies have consistently validated the effectiveness of Ion robotic bronchoscopy through real-world evidence, comparative analyses, and technical evaluations, solidifying its importance in modern lung nodule diagnostics.
Stay Ahead in Today’s Competitive Market!
Unlock your company’s full potential with a Virtual Delivery Center (VDC). Gain specialized expertise, drive
seamless operations, and scale effortlessly for long-term success.
Book a Meeting to Avail the Services of Vinsi AI